245 related articles for article (PubMed ID: 36769334)
21. GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.
Park HH; Kwon HS; Lee KY; Kim YE; Son JW; Choi NY; Han MH; Park DW; Kim S; Koh SH
Aging (Albany NY); 2024 Jan; 16(3):1983-2004. PubMed ID: 38301041
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
23. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
24. Flavanol-rich lychee fruit extract substantially reduces progressive cognitive and molecular deficits in a triple-transgenic animal model of Alzheimer disease.
Chen X; Xu B; Nie L; He K; Zhou L; Huang X; Spencer P; Yang X; Liu J
Nutr Neurosci; 2021 Sep; 24(9):720-734. PubMed ID: 31603034
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
Martínez-Drudis L; Sheta R; Pellegrinato R; Loukili S; Tremblay C; Calon F; Rivest S; Oueslati A
Neurobiol Dis; 2022 Oct; 172():105833. PubMed ID: 35905928
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
[TBL] [Abstract][Full Text] [Related]
27. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
[TBL] [Abstract][Full Text] [Related]
28. Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model.
Landry O; François A; Oye Mintsa Mi-Mba MF; Traversy MT; Tremblay C; Emond V; Bennett DA; Gylys KH; Buxbaum JD; Calon F
J Neurosci; 2023 Jun; 43(26):4941-4954. PubMed ID: 37253603
[TBL] [Abstract][Full Text] [Related]
29. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer's disease-associated markers in 3xTg-AD mice.
Kapadia M; Mian MF; Ma D; Hutton CP; Azam A; Narkaj K; Cao C; Brown B; Michalski B; Morgan D; Forsythe P; Zovkic IB; Fahnestock M; Sakic B
Alzheimers Res Ther; 2021 Jan; 13(1):30. PubMed ID: 33472690
[TBL] [Abstract][Full Text] [Related]
31. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
[TBL] [Abstract][Full Text] [Related]
32. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.
Choi BR; Cho WH; Kim J; Lee HJ; Chung C; Jeon WK; Han JS
Exp Mol Med; 2014 Feb; 46(2):e75. PubMed ID: 24503708
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
35. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
[TBL] [Abstract][Full Text] [Related]
36. Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3×Tg-AD Model Mice.
Goto T; Kuramoto E; Dhar A; Wang RP; Seki H; Iwai H; Yamanaka A; Matsumoto SE; Hara H; Michikawa M; Ohyagi Y; Leung WK; Chang RC
J Alzheimers Dis; 2020; 76(4):1443-1459. PubMed ID: 32651317
[TBL] [Abstract][Full Text] [Related]
37. Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer's disease mouse model.
Lin X; Chen L; Baglietto-Vargas D; Kamalipour P; Ye Q; LaFerla FM; Nitz DA; Holmes TC; Xu X
Neurobiol Dis; 2022 Jan; 162():105562. PubMed ID: 34838667
[TBL] [Abstract][Full Text] [Related]
38. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
39. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease.
Bories C; Arsenault D; Lemire M; Tremblay C; De Koninck Y; Calon F
Aging (Albany NY); 2017 May; 9(5):1386-1403. PubMed ID: 28522792
[TBL] [Abstract][Full Text] [Related]
40. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
